Expert Pitch

Rutgers Expert Available to Discuss COVID-19 Vaccine Hesitancy Among Latinos/as

Yonaira Rivera, a Rutgers University–New Brunswick assistant professor of communication, is available to discuss the role misinformation plays in COVID-19 vaccine hesitancy among U.S. Latinos/as and other communities of color.

“While issues related to vaccine hesitancy go beyond social media, evidence suggests that these platforms contribute to the spread of misinformation that can bolster these beliefs and misperceptions,” said Rivera. “My research on cancer misinformation on social media, which focuses on Latinos ages 40-75, highlights that many individuals do not have the time, skills or motivation to adequately verify content they encounter. Instead, they trust the sources who share it – despite the content having low scientific credibility and being distributed by potentially unreliable sources. These findings suggest we should address digital health literacy among adult populations to help reduce the spread of health misinformation. But interventions at the platform level are also imperative, as individuals may not be sufficiently motivated or skilled to verify the health information they encounter on social media.”

Rivera testified April 15 before the Subcommittee on Communications, Media and Broadband, part of the U.S. Senate Committee on Commerce, Science and Transportation, during the “Shot of Truth: Communicating Trusted Vaccine Information” hearing.

Rivera addressed three critical areas: the role of social media in the spread of misinformation about COVID-19 and the power of such misinformation to undermine coronavirus vaccine communication campaigns among Latino and other Black, Indigenous and people of color communities; effective methods and tactics to reach Latino and other Black, Indigenous and people of color communities with evidence-based messages to effectively increase their willingness to become vaccinated; and lastly, the need for more research to understand these broad and complicated issues. 

Rivera specializes on understanding how Latino communities engage with health information and misinformation on social media, and how this engagement can impact their health decisions. She is also a co-founder of the grassroots organization Puerto Rico Stands, which she helped organize after Hurricane María to assist community leaders in Puerto Rico find and implement long-term relief efforts. 

###

Broadcast interviews: Rutgers University–New Brunswick has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts.

ABOUT RUTGERS—NEW BRUNSWICK

Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship university is a leading public research institution and a member of the prestigious Association of American Universities. It is home to internationally acclaimed faculty and has 12 degree-granting schools and a Division I Athletics program. It is the Big Ten Conference’s most diverse university. Through its community of teachers, scholars, artists, scientists, and healers, Rutgers is equipped as never before to transform lives.



Filters close

Showing results

1120 of 5809
Released: 10-Jun-2021 4:05 PM EDT
Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
Cleveland Clinic

A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

Released: 10-Jun-2021 3:25 PM EDT
5 Leadership Strategies for Better Adapting in a Crisis
University of Maryland, Robert H. Smith School of Business

Maryland Smith management expert and futurist Oliver Schlake describes how companies can prepare for the next crisis as the economy gradually emerges from the COVID-19 pandemic.

7-Jun-2021 2:30 PM EDT
COVID-19 Creates Hearing, Balance Disorders, Aggravates Tinnitus Symptoms
Acoustical Society of America (ASA)

Evidence suggests auditory and vestibular effects should be added to the growing list of physiological impacts of COVID-19. During the 180th Meeting, Colleen Le Prell from the University of Texas at Dallas will talk about hearing and balance disorders associated with coronavirus infection and how pandemic-related stress and anxiety may aggravate tinnitus symptoms. Her presentation, "Hearing disorders secondary to infection with SARS-CoV-2," will take place Thursday, June 10.

Released: 10-Jun-2021 10:55 AM EDT
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Newswise:Video Embedded doe-scientists-deploy-creativity-speed-to-disrupt-covid-19
VIDEO
Released: 10-Jun-2021 9:00 AM EDT
DOE scientists deploy creativity, speed to disrupt COVID-19
Oak Ridge National Laboratory

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

Released: 10-Jun-2021 9:00 AM EDT
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Imperial College London

New research shows transmission of the virus behind COVID-19 varies seasonally, but warmer conditions are not enough to prevent transmission.

8-Jun-2021 12:45 PM EDT
Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Mayo Clinic

Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.

4-Jun-2021 2:25 PM EDT
Study Examines COVID-19 Among Patients Receiving Home Dialysis
American Society of Nephrology (ASN)

• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.

4-Jun-2021 2:30 PM EDT
Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis
American Society of Nephrology (ASN)

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination. • Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.

Newswise: New treatment demonstrated for people with vaccine clots
8-Jun-2021 10:50 AM EDT
New treatment demonstrated for people with vaccine clots
McMaster University

The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.


Showing results

1120 of 5809

close
2.04464